Form 4 for ABUS Arbutus Biopharma Corp
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-14 · accession 0001447028-24-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-16 | 2024-08-14 | ABUS | MANCHESTER KEITH S | Dir | S - Sale+OE | $3.69 | -8,846 | 46.1K | -16% | -$32.6K |
| D | 2024-08-16 | 2024-08-14 | ABUS | MANCHESTER KEITH S | Dir | M - OptEx | $0.56 | +54.9K | 54.9K | New | +$30.8K |
| D | 2024-08-16 | 2024-08-14 | ABUS | MANCHESTER KEITH S | Dir | M - OptEx | $0.00 | -54.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-08-14 | S | D | 8,846 | $3.69 | 46,069 | D | — | — | |
| 2 | Common | Common Shares | 2024-08-14 | M | A | 54,915 | $0.56 | 54,915 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-14 | M | D | 54,915 | $0.00 | 0 | D | $0.56 · — to 2024-11-13 | 54,915 Common Shares | (F2) This is a director stock option grant that is fully vested. |